Home/Filings/4/0001127602-21-019553
4//SEC Filing

Sandrock Alfred 4

Accession 0001127602-21-019553

CIK 0000875045other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 7:05 PM ET

Size

4.8 KB

Accession

0001127602-21-019553

Insider Transaction Report

Form 4
Period: 2021-06-07
Sandrock Alfred
Grp SVP, Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-06-07$440.00/sh7,672$3,375,68010,169.112 total
Footnotes (2)
  • [F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F2]Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001577061

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 7:05 PM ET
Size
4.8 KB